iShares U.S. Healthcare ETF

iShares Trust · 1 share class

U.S. equity index ETF
One fund, 1 share class:IYH
$2.80B NAV
106 positions · as of 2026-04-30 · filed 2026-06-25

Fund classification

Classified from what the fund holds · as of 2026 Q2

iShares U.S. Healthcare ETF is a U.S. equity index ETF that tracks the Russell 1000 Health Care RIC 22.5/45 Capped Index. 18% of IYH’s stock holdings are in companies whose revenue grew in the top quartile of U.S. companies over the last five fiscal years (covering 99% of the fund’s equity).

Asset class
Equity
Region
United States
Management
Index (passive)
Fund type
ETF
Features
Non-diversified

Fund profile

As filed in the prospectus · 2025 Q3

The iShares U.S. Healthcare ETF (the Fund ) seeks to track the investment results of an index composed of U.S. equities in the healthcare sector.

Strategy · summarised

The fund tracks the Russell 1000 Health Care RIC 22.5/45 Capped Index using representative sampling, holding a sample of healthcare securities with investment characteristics similar to the index rather than all constituents. The index caps any single issuer at 22.5% weight and limits issuers over 4.5% to 45% combined weight at quarterly rebalance, though market movements between rebalances may cause weights to exceed these caps. Because the fund samples rather than fully replicates the index, its returns may diverge from the index it seeks to track.

Expenses
0.38%one share class
Share classExpense ratio
IYH0.38%

Portfolio turnover 4.00% · as of 2025 Q3

Allocation

Asset groups · long / short shown separately, never netted · 2026 Q2

100.59%
of net assets
Stocks99.81%
Cash & short-term0.79%
Derivatives-0.00%

The outer band is exposure held short — written against the portfolio rather than part of it, which is why it sits outside the ring and why the two are never netted into one figure.

Derivatives are shown at market value, not notional exposure.

Sector allocation

The same holdings as Allocation above, grouped by market sector instead of asset type · as of 2026 Q2

100%
of net assets
Health Care99.1%
Cash0.8%
International0.1%
Other0.0%

Government, Securitized and Cash are non-corporate buckets; International is foreign holdings we don’t sector-classify, and Other is the residual (held funds, unresolved names).

Portfolio growth profile

How much of the fund’s stock holdings are in fast-growing companies · as of 2026 Q2

Revenue growth
18%of stock holdings in top-quartile growers
covering 99% of the fund’s equity
Earnings growth
20%of stock holdings in top-quartile growers
covering 93% of the fund’s equity

Share of the fund’s equity (by value) in companies whose trailing five-year revenue — or net-income — growth ranks in the top 25% of U.S. public companies. Foreign and newly-listed holdings are excluded, so the figure covers only part of the book. From SEC filings — not investment advice. How we measure this.

Latest quarter

What changed since the fund's previous filing

2026Q2 vs 2026Q1: 3 new3 exited

New: MDLN, XAV HEALTH CARE JUN26, HOLOGIC INC CVR

Exited: EXACT SCIENCES CORPORATION, HOLOGIC, INC., XAV HEALTH CARE MAR26

Return profile

Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026

1-year
+5.99%
3-year
+13.15%
5-year
+23.67%
Volatility
15.96%
Worst 3-yr fall
-16.31%
Cumulative return· May 2023 – Apr 2026

Holdings

By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page

Issuer%NAVValue
ELI LILLY AND COMPANYLLY13.72%$384.59M
JOHNSON & JOHNSONJNJ10.14%$284.11M
ABBVIE INC.ABBV6.86%$192.29M
UNITEDHEALTH GROUP INCORPORATEDUNH6.18%$173.17M
MERCK & CO., INC.MRK4.97%$139.37M
AMGEN INC.AMGN3.41%$95.66M
THERMO FISHER SCIENTIFIC INCORPORATEDTMO3.32%$92.91M
GILEAD SCIENCES, INC.GILD2.99%$83.70M
INTUITIVE SURGICAL, INC.ISRG2.96%$82.97M
ABBOTT LABORATORIESABT2.88%$80.75M
Showing 10 of 106Sign in to see more

Reported price is the fund's own reported value divided by its own reported shares at 2026-04-30 — not a live quote, and not what the fund paid.

Top 10 positions are 57.44% of net assets, top 25 81.00%, across 106 issuers.

See more of this fund's book

More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.

Sign in free